(Q48967659)

English

A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis.

scientific article published in July 1996

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit